⌘K

Home/Filings/4/0001209191-21-064855

4//SEC Filing

Ives Jeffrey L. 4

Accession 0001209191-21-064855

CIK 0001346830other

View on SEC.gov Company Profile

Filed

Nov 15, 7:00 PM ET

Accepted

Nov 16, 6:15 PM ET

Size

4.6 KB

Accession

0001209191-21-064855

Insider Transaction Report

Form 4

Period: 2021-11-12

Cara Therapeutics, Inc.CARA

Ives Jeffrey L.

Director

Transactions

Sale
Common Stock
2021-11-12$16.04/sh−8,180$131,207→ 7,200 total

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Cara Therapeutics, Inc.

CIK 0001346830

Entity typeother

Related Parties

1

filerCIK 0001614096

Filing Metadata

Form type: 4
Filed: Nov 15, 7:00 PM ET
Accepted: Nov 16, 6:15 PM ET
Size: 4.6 KB

View on SEC.gov